Omeros (OMER) Shares Repurchased (2023 - 2026)
Omeros recorded quarterly Shares Repurchased of $4.2 million in Q1 2026, down 64.96% quarter-over-quarter from $11.9 million in Q1 2024.
Omeros' Shares Repurchased history runs 3 years deep, the most recent figure standing at $4.2 million for Q1 2026.
- In Q1 2026, Shares Repurchased changed N/A year-over-year to $4.2 million; the TTM figure through Mar 2026 stood at $4.2 million (changed N/A YoY), while the FY2024 annual figure was $11.9 million, up 154.64% from the prior year.
- Shares Repurchased came in at $4.2 million for Q1 2026 at Omeros, down from $11.9 million in the prior quarter.
- In the past five years, Shares Repurchased ranged from a high of $11.9 million in Q1 2024 to a low of $4.2 million in Q1 2026.
- A 3-year average of $6.9 million and a median of $4.7 million in 2023 frame the typical range for Shares Repurchased.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 336.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 794.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | 4.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.15 Mn |
| Mar 31, 2026 | 4.15 Mn |
| Mar 31, 2024 | 11.85 Mn |
| Mar 31, 2024 | 11.85 Mn |
| Dec 31, 2023 | 4.65 Mn |
| Dec 31, 2023 | 4.65 Mn |